Navigation Links
Paragon Bioservices Awarded $4.99 Million U.S. Army Contract to Assist with Ebola Vaccine Development
Date:10/21/2010

BALTIMORE, Oct. 21 /PRNewswire/ -- Paragon Bioservices, a Baltimore-based CMO focused on the contract research, process development and manufacturing of biologics, announced today that it has been awarded a $4.99 million contract to assist the U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID) in its vaccine development efforts.

The USAMRIID project involves process development and scale-up production of VLP-type vaccines against Ebola Zaire, Ebola Sudan, and Marburg viruses to support ongoing preclinical evaluation of efficacy, potency, and safety of these Filovirus vaccine candidates.  Utilizing their extensive VLP production and purification expertise, Paragon will develop a large-scale mammalian process suitable for future GMP manufacturing.

Ebola and Marburg viruses are a serious global health threat.  They cause hemorrhagic fever and have up to a 90 percent fatality rate in humans.  Currently, there are no vaccines or therapies available for these viruses.  They are commonly spread through blood and bodily fluids of infected patients who frequently succumb to hypovolemic shock.  Both viruses are potential agents of biological warfare or terrorism, since both are also infectious by aerosol.

Marco Chacon, Ph.D., CEO of Paragon Bioservices, commented, "As a scientist and a business man, it is extremely rewarding to be part of an effort that may improve public health, as well as enhance national preparedness.  Preventing the spread of Ebola and Marburg viruses is crucial to containing outbreaks and saving lives."

About Paragon BioservicesParagon Bioservices is a CMO focused on providing contract research, process development services and GMP manufacturing of biologics for Phase I/II clinical trials.  For more information about Paragon Bioservices, please visit www.paragonbioservices.com.

About USAMRIIDUSAMRIID, a division of the U.S. Army Medical Research and Materiel Command, plays a key role in both national defense and infectious disease research.  They are the lead medical research laboratory for the Department of Defense and the Biological Defense Research Program.  Their mission is essentially to conduct basic research on biological threats and to develop appropriate medical solutions—such as vaccines, drugs and diagnostics.Media Contacts:Tiberend Strategic Advisors, Inc.(212) 827-0020 Tamara Brighttbright@tiberendstrategicadvisors.comorClaire Sojdacsojda@tiberendstrategicadvisors.com
'/>"/>

SOURCE Paragon Bioservices
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Paragon Bioservices, Inc. Wins 2009 Lilly Global Supplier Award
2. ParagonRx Creates New Website Featuring REMS Help Center for Pharma
3. ParagonRx Files with FDA REMS Panel Interim Analysis for Opioid Drugs Study
4. ParagonRx Sponsors Webinar-on-Demand By DSEC on Role of Drug Safety Officers
5. Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone Single-Use Bioreactor Systems
6. Avid Bioservices Presents Data From Manufacturing Successes Achieved With Single-Use Bioreactor Systems
7. Avid Bioservices Expands Executive Team as it Prepares for Continued Growth
8. Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
9. Dr. Yong Shi awarded NSF grant
10. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
11. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 Research and Markets has announced ... Markets and Companies" to their offering. ... , , ... and biotechnology industries is anticipated. Nanotechnology will be applied at ... delivery to diagnostic applications in clinical trials. Many of the ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 01, 2016 ... ... the US Computational Science Symposium (CSS) and the popularity of US Single Day ... will take place in early Summer 2018, in Raleigh, NC. Topics of the ...
(Date:12/2/2016)... (PRWEB) , ... December 02, ... ... (ETC), a consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing ... companies interested in supplying a vendor-supported, portable online UHPLC, with robust, probe-based ...
(Date:12/2/2016)... /PRNewswire/ - bioLytical Laboratories, a world leader in rapid infectious disease tests, introduced the ... Pharmaceutical Association members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ... ... , , bioLytical ... (KPA) to introduce the INSTI HIV Self Test to 350 pharmacy representatives in ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov 15, 2016 Research and ... Global Forecast to 2021" report to their offering. ... ... USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, ... Growth of the bioinformatics market is driven by the ...
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/20/2016)... -- Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring announced that after exhaustive ... the final acceptance by all three (3) Department ... (MAS) installed. Furthermore, Securus will have contracts for ... October, 2016. MAS distinguishes between legitimate wireless device ...
Breaking Biology News(10 mins):